Research has revealed that various inhibitory checkpoints of the B7 family are elevated in tumors, leading to the spread of cancer cells by immunosuppression; thus, blocking the B7 family members could enhance anti-tumor immune responses. The gene discussed is CD80; the disease is neoplasm.